PROPOFOL 200 MG/20 ML VIAL

What it is

PROPOFOL 200 MG/20 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “propofol” and “propofol injectable emulsion”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as injection, emulsion and its route as intravenous.

Its labelers, the companies named on the label, are Hospira, Inc., Sagent Pharmaceuticals and Dr. Reddy's Laboratories, Inc.

FDA’s Established Pharmacologic Class for it is General Anesthetic.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.42 for 20 mL (20 × $0.17094 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-08-19 and 2026-09-02. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

The NADAC of all 4 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-08-19, 2026-09-02. The file is new; the price is not.

What NADAC measures · NADAC explanation codes · Carried-forward prices

All 4 NDCs

• 00409-1511-98 · Hospira, Inc. · $0.17094 per ML · eff. 2026-09-02 filed carried forward
• 00409-6010-25 · Hospira, Inc. · $0.17094 per ML · eff. 2026-08-19 filed carried forward
• 25021-0608-20 · Sagent Pharmaceuticals · $0.17094 per ML · eff. 2026-08-19 filed carried forward
• 43598-0265-25 · Dr. Reddy's Laboratories, Inc. · $0.17094 per ML · eff. 2026-08-19 filed carried forward

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with PROPOFOL 200 MG/20 ML VIAL.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-02 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $0.17094 per ML filed.

Of the 4 other products in FDA’s General Anesthetic class priced per ML, 3 have a higher middle NADAC price and 0 a lower one; 1 has the same. The one in the middle is KETAMINE 500 MG/10 ML VIAL, at $0.5563 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part B’s payment limit for HCPCS J2704, for 2026-10-01 to 2026-12-31, comes to $1.86 for 20 mL, or $0.093 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.0186 per 10 MG.

3 of the product’s 4 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 20 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 20 mL; your package may hold a different amount.
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.